This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovations of Ingrid Struman
Introduction
Ingrid Struman is a notable inventor based in Faimes, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of antiangiogenic peptides. Her work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Ingrid Struman holds a patent for her invention titled "Antiangiogenic peptide agents." This invention provides novel antiangiogenic peptides that correspond to about 133 consecutive amino acids of the N-terminal sequence of growth hormone. This groundbreaking work has the potential to impact therapeutic approaches in treating various diseases.
Career Highlights
Ingrid Struman is affiliated with the University of California, where she continues to engage in research and development. Her academic background and professional experience have positioned her as a leader in her field. She has demonstrated a strong dedication to her work, contributing to advancements in biotechnology.
Collaborations
Ingrid has collaborated with esteemed colleagues, including Richard I. Weiner and Joseph A. Martial. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Ingrid Struman's innovative work in antiangiogenic peptides exemplifies her dedication to advancing medical science. Her contributions are paving the way for future breakthroughs in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile